Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Axsome Therapeutics
AXSM
$10.9B
| $52.8M | 0.03% |
735,103
-304,264
| -29% | -$22.4M |
|
702
PUT
DuPont de Nemours
DD
$18.7B
| $52.7M | 0.03% |
587,382
-1,195
| -0.2% | -$103K |
|
703
RLI Corp
RLI
$6B
| $52.7M | 0.03% |
+771,782
| New | +$51.3M |
|
704
JB Hunt Transport Services
JBHT
$25.9B
| $52.5M | 0.03% |
289,983
+154,306
| +114% | +$26.8M |
|
705
PUT
Uber
UBER
$161B
| $52.2M | 0.03% |
1,210,200
+786,100
| +185% | +$29.2M |
|
706
Dentsply Sirona
XRAY
$2.18B
| $52.1M | 0.03% |
1,302,512
+1,268,147
| +3,690% | +$50.4M |
|
707
Flywire
FLYW
$2.38B
| $52.1M | 0.03% |
1,677,032
-158,249
| -9% | -$4.75M |
|
708
FMC
FMC
$1.38B
| $52M | 0.03% |
498,671
-577,396
| -54% | -$64.9M |
|
709
Alkermes
ALKS
$8.11B
| $51.9M | 0.03% |
1,659,031
-859,487
| -34% | -$26M |
|
710
PUT
Procter & Gamble
PG
$336B
| $51.9M | 0.03% |
341,900
-166,400
| -33% | -$25.1M |
|
711
General Mills
GIS
$21.4B
| $51.9M | 0.03% |
676,106
+598,869
| +775% | +$51.2M |
|
712
Accenture
ACN
$113B
| $51.8M | 0.03% |
167,794
+129,251
| +335% | +$37.6M |
|
713
Insulet
PODD
$10.3B
| $51.7M | 0.03% |
179,274
+175,350
| +4,469% | +$53.3M |
|
714
Vale
VALE
$62.1B
| $51.6M | 0.03% |
3,844,285
-3,922,020
| -51% | -$55.5M |
|
715
PUT
Elevance Health
ELV
$86.9B
| $51.5M | 0.03% |
116,000
+30,200
| +35% | +$13.9M |
|
716
PUT
Aon
AON
$75.3B
| $51.2M | 0.03% |
148,300
+1,100
| +0.7% | +$357K |
|
717
IBM
IBM
$222B
| $51.1M | 0.03% |
382,200
-920,163
| -71% | -$119M |
|
718
Bank OZK
OZK
$5.39B
| $51.1M | 0.03% |
1,272,454
-731,397
| -36% | -$26.2M |
|
719
Twist Bioscience
TWST
$9.13B
| $51.1M | 0.03% |
2,497,414
+2,479,424
| +13,782% | +$37.1M |
|
720
First Industrial Realty Trust
FR
$8.34B
| $51.1M | 0.03% |
969,795
-65,697
| -6% | -$3.43M |
|
721
Equinix
EQIX
$105B
| $51M | 0.03% |
65,066
-24,985
| -28% | -$18.3M |
|
|
IMGN
722
DELISTED
Immunogen Inc
IMGN
| $50.9M | 0.03% |
2,697,863
-279,061
| -9% | -$3.29M |
|
|
SNV
723
DELISTED
Synovus
SNV
| $50.8M | 0.03% |
1,680,393
+621,375
| +59% | +$18.2M |
|
|
SYNH
724
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $50.7M | 0.03% |
1,203,316
+206,220
| +21% | +$8.34M |
|
725
Cleveland-Cliffs
CLF
$6.43B
| $50.6M | 0.03% |
3,020,677
+413,310
| +16% | +$6.56M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.